SANOFI-AVENTIS KK, ASTELLAS DISCONTINUE MARKETING ALLIANCE

Sanofi-Aventis KK and Astellas Pharma Inc., Japan, have agreed to discontinue the marketing alliance on September 30, 2006 for Ketek Tablets 300 mg (generic name: telithromycin), ketolide antibiotic. BioSpectrum (http://www.biospectrumasia.com/content/220806JPN1401.asp)